Back to search

Article

Association of IL7 rs16906115 Polymorphism with Adverse Events in Patients with Advanced Lung Cancer Undergoing Immunotherapy

2026-01-13

Abstract excerpt

<h4>Background: </h4> Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced non-small cell lung cancer (aNSCLC). However, immune-related adverse events (irAEs) remain a clinical challenge in this context. Genetic variants acting as cis-eQTLs may predict toxicity risk, thereby enabling personalized treatment. We investigated the association between the IL7 rs16906115 polymorphism, advers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f937c2b9-7531-5b07-95cc-9299ef123234
DOI
10.20944/preprints202601.0898.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association of IL7 rs16906115 Polymorphism with Adverse Events in Patients with Advanced Lung Cancer Undergoing ImmunotherapyDOI 10.20944/preprints202601.0898.v1
Select a neighboring publication to make it the new centre.